Industry Updates
Press Releases
Bernhard Dräger Award for Treatment of Acute Respiratory Failure awarded to Dr Hermann Heinze
The European Society for Intensive Care Medicine (ESICM) has awarded the first ‘Bernhard Dräger Award for Advanced Treatment of Acute Respiratory Failure’ to Dr Hermann Heinze, from the Clinic for Anesthesiology and Intensive Care Medicine at the Schleswig-Holstein University...
Press Releases
U.K’s National health service supply chain ranks Zoll R Series defibrillator at highest value
ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, announced that its new R Series® Code-Ready™ clinical defibrillator has received the highest overall score of all devices evaluated by the United Kingdom’s National Health Service Supply...
Press Releases
Peak Surgical Preclinical Study of PEAK PlasmaBlade Needle showing positive results
PEAK Surgical, Inc., a medical device company that has developed a new tissue dissection system based on a proprietary technology, announced preclinical study results showing that its PEAK PlasmaBladeTM Needle cuts tissue with significantly reduced thermal tissue injury compared...
Press Releases
Bayer HealthCare acquires German DIREVO Biotech AG
Bayer HealthCare AG acquires the German biotech company DIREVO Biotech AG, Cologne. With the acquisition of the biotech company specialized in protein engineering, Bayer strengthens the research competence in biologicals of its pharmaceutical division Bayer Schering Pharma. The industrial...
Press Releases
Elekta announces next-generation radiation treatment technologies at ESTRO 27
With its new re-locatable frame, EXTEND offers maximum stability, enabling the most accurate, non-invasive localization available and now allows clinicians to explore the possibility to treat large or critically located targets in the head and neck that were previously...
Press Releases
Siemens announces study results of new imaging Biomaker
Recent developments of new imaging biomarkers may open doors to new treatment pathways in oncology. Moving personalized medicine from promise to practice, Siemens Healthcare (www.siemens.com/healthcare) announces the early study findings of a new imaging biomarker for hypoxic tumors. The...
Press Releases
Abbott’s HUMIRA® (adalimumab) Approved in the European Union for the Treatment of Polyarticular…..
Abbott announced that the European Commission has granted marketing authorization for the use of HUMIRA®, in combination with methotrexate (MTX), as a treatment for active polyarticular juvenile idiopathic arthritis (JIA) in adolescents aged 13 to 17. Additionally, HUMIRA for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
